Predictive Oncology

AUGUST 15, 2024

White paper validates highly reproducible drug response data. Complete the form below to download the white paper. The post Heterogeneous and curated biobank of live-cell tumor samples retains highly reproducible drug response data for drug and biomarker discovery appeared first on Predictive Oncology.

Drugs 52

Drugs Drug Development 52

Predictive Oncology

AUGUST 8, 2024

A recent white paper released by Predictive Oncology’s highlights the challenge of late-stage clinical trial failures and the company’s ability to better navigate those obstacles and increase the probability of technical success which is a key metric in target selection, clinical trial design and pipeline replenishment.

Drug Development 52

Drug Development Clinical Trials Animal Testing Trials 52

Predictive Oncology

JULY 26, 2024

EndoPrep as a sample treatment system to be used with FUJIFILM PYROSTAR ES-F/Plate Download white paper here Interested in partnering with us? Please fill out the form below. appeared first on Predictive Oncology.

Treatment 52

Treatment 52

Fierce BioTech

JUNE 24, 2024

An Integrated End-to-End Approach to Antibody Drug Conjugate Development and Manufacturing In this white paper, Lonza experts delve into the common challenges encountered by ADC developers. Read this white paper to learn more. Read this white paper to learn more.

Drugs 52

Drugs Drug Development Production Research 52

Fierce BioTech

JULY 18, 2024

Efficient-Pro Medium and Feed 1 enable rapid and seamless upstream process development and scale-up for CHO-K1 cells Download the white paper to learn how this innovative solution can help optimize your mAb production processes.

Laboratories 52

Laboratories Production 52

PPD

OCTOBER 8, 2024

The PPD™ clinical research business of Thermo Fisher Scientific helps clients create all manner of flexible outsourcing solutions, many of which are detailed in our recent white paper, “Establishing a Bespoke Outsourcing Arrangement with Hybrid FSP/FSO Partnerships.”

Trials 98

Trials Clinical Trials Clinical Development Clinical Research 98

Fierce BioTech

OCTOBER 17, 2024

This white paper details the importance of quality assessments from preclinical to commercial phases. Planning for success in cell-based manufacturing Selecting quality raw materials is crucial for developing GMP-compliant processes for recombinant proteins and monoclonal antibodies.

52

52

Fierce BioTech

MAY 29, 2024

Read this white paper to learn more. Read this white paper to learn more. lbarrick Wed, 05/29/2024 - 10:41 New molecular formats are gaining momentum in today’s market.

Treatment 52

Treatment Disease Production Marketing 52

Fierce BioTech

APRIL 10, 2024

Get your FREE white paper to understand the challenges in disease diagnosis, the impact of antibody biomarkers, and the nuances of antibody screening for biomarker discovery.

Disease 52

Disease 52

Fierce BioTech

MAY 14, 2024

Your Guide to the Ultimate Pharmaceutical Product Improvement Tool This white paper will review how automating the annual product quality review (APQR) process can help pharmaceutical companies simplify and optimize their product quality review process, to make informed product quality decisions quicker and on a more routine and proactive basis.

Production 52

Production Pharmaceuticals Pharmaceutical Companies 52

Fierce BioTech

APRIL 10, 2024

Download this white paper to learn how Lonza has developed a novel workflow to ensure confidence regarding functionality in PFS and autoinjectors. Download this white paper to learn how Lonza has developed a novel workflow to ensure confidence regarding functionality in PFS and autoinjectors.

Marketing 52

Marketing 52

SCIENMAG: Medicine & Health

MARCH 27, 2024

Philadelphia, March 28, 2024 – Although the vast majority of clinicians do not view atrial fibrillation (AF) as a genetic disorder, a White Paper in the Canadian Journal of Cardiology, published by Elsevier, analyzes the current understanding of genetics and the role of genetic testing in AF and concludes there is an increasing appreciation that […] (..)

67

67

SCIENMAG: Medicine & Health

JULY 18, 2023

In a new white paper commissioned by the National Academies of Sciences, Engineering, and Medicine (NASEM), Lepech and Li study the current status, challenges, and needs of recycling plastics in a circular economy, and examine the long-term durability and environmental […]

Engineering 90

Engineering Science 90

Alta Sciences

SEPTEMBER 5, 2024

New Findings on the Sinclair Nanopig™ in Safety Studies blussier Thu, 09/05/2024 - 18:00 HTML Recent Scientific Data Challenges the Status Quo Our most recent white paper presents detailed genomic, proteomic, and functional data on the Sinclair Nanopig™’s metabolism and immune systems. Read it now! ​​​​​​ WHITE PAPER Questions?

Drug Development 40

Drug Development Drugs Research 40

Fierce BioTech

JANUARY 26, 2024

This white paper is a culmination of insights from leaders in the field and proprietary data analysis, offering a guide to modernizing patient recruitment strategies in clinical trials. Blueprint for Modern Patient Recruitment Every day, a clinical trial is delayed due to recruitment planning issues. Download now. Download now.

Clinical Trials 52

Clinical Trials Trials Science 52

Fierce BioTech

DECEMBER 22, 2023

This white paper explains how Resilience utilizes a Stage-Gate approach to technology transfer and biomanufacturing. This white paper explains how Resilience utilizes a Stage-Gate approach to technology transfer and biomanufacturing. Download now.

Research 52

Research 52

Fierce BioTech

DECEMBER 21, 2023

Location Matters: The Value of a Phased Approach to Medical Device Site Strategy Unlock the secrets to successful manufacturing site investment with this white paper. dfarris Thu, 12/21/2023 - 09:10 Unlock the secrets to successful manufacturing site investment with this white paper.

52

52

Alta Sciences

OCTOBER 28, 2024

White Paper: Whole Genome Sequencing, Proteomics, and Function Characterization of the Sinclair Nanopig™ Discover how the Sinclair Nanopig™ is transforming nonclinical safety assessments. Read the white paper. Watch it now.

Science 52

Science Clinical Trials Trials FDA 52

Fierce BioTech

NOVEMBER 27, 2023

In this white paper you'll learn factors influencing the rate of change, including specialties, demographics, and more. In this white paper you'll learn factors influencing the rate of change, including specialties, demographics, and more. The healthcare provider landscape is incredibly dynamic. Download now.

52

52

Drug Channels

SEPTEMBER 22, 2023

To learn about CoverMyMeds’ medication affordability solutions that engage patients, download the CoverMyMeds white paper: Overcoming Affordability Challenges with Patient-Centered Solutions. Read on for Kristina’s insights. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Pharmacy 91

Pharmacy Production Drugs 91

Alta Sciences

JULY 23, 2024

Whole Genome Sequencing, Proteomics, and Function Characterization of the Sinclair Nanopig™ for (Bio)Pharmaceuticals Safety Assessment tchichekian Tue, 07/23/2024 - 12:14 Publication White paper_Sinclair Nanopig Data_v3.pdf pdf Tags Preclinical Research URL [link] Category White Paper Weight 5

Pharmaceuticals 40

Pharmaceuticals Research 40

Fierce BioTech

JULY 28, 2023

jsabatino Fri, 07/28/2023 - 11:29 In this white paper, we look at the past, present and future of antibodies as therapies, explaining how the modality became a key pillar of the biopharma industry—and looking forward to the methods and technologies that could unleash its full potential in the years to come. Download here!

Therapies 52

Therapies Drug Development Research Drugs 52

Fierce BioTech

NOVEMBER 6, 2023

This white paper delivers an analysis of critical success factors for effective technology transfer. This white paper delivers an analysis of critical success factors for effective technology transfer. This white paper delivers an analysis of critical success factors for effective technology transfer.

Production 52

Production 52

SCIENMAG: Medicine & Health

JUNE 23, 2023

Reston, VA—Leaders from 12 nuclear medicine organizations around the world have issued a white paper about the challenges and opportunities in theranostics education. Published in the June issue of The Journal of Nuclear Medicine, the report outlines the current theranostic educational and accreditation offerings across the globe.

70

70

Drug Channels

SEPTEMBER 22, 2023

To learn about CoverMyMeds’ medication affordability solutions that engage patients, download the CoverMyMeds white paper: Overcoming Affordability Challenges with Patient-Centered Solutions. Read on for Kristina’s insights. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Pharmacy 74

Pharmacy Production Drugs 74

The Pharma Data

FEBRUARY 5, 2021

In this white paper, H. Download the white paper to understand: The different types of data within an organization, and the challenges they pose. Unleash the power of distributed data management by downloading the white paper. Oberkampf, C. Senger and M.

Production 52

Production Marketing Research 52

Fierce BioTech

NOVEMBER 13, 2023

Download this White Paper today to learn more. Effective Technology Transfers for Mammalian-Derived Biologics As a leader of technology transfer activities in the industry, Lonza understands the challenges associated with this critical step.

Research 52

Research 52

Conversations in Drug Development Trends

MARCH 12, 2024

For a more in-depth look at biomarkers, check out our white paper. The IO biomarker field is rapidly evolving—check out this white paper for the latest details regarding IO biomarkers. Below, we discuss some validated circulating oncology biomarkers, their implementation, and key operational considerations.

Clinical Trials 72

Clinical Trials Immune Response Trials Disease 72

PPD

NOVEMBER 18, 2024

There are many nuances to ensuring that the RI gathered and monitored is as effective as possible (as discussed in our recent white paper on the topic). Download our white paper The post Leveraging FSP Solutions and Expertise to Keep Up With Regulatory Intelligence Systems Monitoring appeared first on PPD.

Clinical Trials 52

Clinical Trials Regulations Compliance Production 52

The Pharma Data

NOVEMBER 16, 2020

White Papers / Tech Papers. While there are many blinding options available, over-encapsulation remains the most popular method adopted by sponsors to meet regulatory demands. Source link.

52

52

The Pharma Data

NOVEMBER 11, 2020

White Papers / Tech Papers. Chewing gum as a dosage format for pharmaceutical applications in the OTC market stands out as a fast growing, innovative dosage format. Source link.

Pharmaceuticals 52

Pharmaceuticals Marketing 52

Conversations in Drug Development Trends

FEBRUARY 21, 2024

We recently published a white paper discussing the value of proactive AME studies, best practices, and lessons we’ve learned over the years to help optimize your study. At Worldwide, our early phase team has conducted these studies for over 20 years, gaining invaluable experience and insights into best practices for an AME study.

Clinical Trials 80

Clinical Trials Pharmacy Clinical Pharmacology FDA 80

Fierce BioTech

JUNE 1, 2023

Download the white paper to learn more about the diagnostic potential of antibodies. Autoantibodies: Powerful Biomarkers in Cancer Precision Medicine Autoantibodies hold great diagnostic potential for early cancer detection. The unique patterns of autoantibody production mirror the highly heterogeneous nature of cancer.

Treatment 52

Treatment Production Research 52

Conversations in Drug Development Trends

MARCH 1, 2024

To help determine if a master protocol could be a good fit for your study, check out this white paper for a more comprehensive overview of the appropriateness of master protocols in different contexts. Here are some relevant factors below: What Are the Advantages of a Master Protocol? Contact us.

Trials 78

Trials Disease Drug Development Clinical Trials 78

PPD

OCTOBER 21, 2024

Our white paper on the topic examines reasons biotech companies use the functional service provider (FSP) model to support their clinical development activities and the value that FSP engagements bring to these organizations.

International 52

International Clinical Development Clinical Trials Clinical Research 52

Advarra

MAY 26, 2023

The Association of American Cancer Institutes (AACI) recently published a white paper titled Collaboration to Develop Recommendations to Improve Trial Activation Timelines. The task force focused on three main areas of study activation: contract negotiation, budget development, and trial start up committee reviews.

Clinical Research 52

Clinical Research Trials Clinical Trials Research 52

The Pharma Data

JANUARY 11, 2021

Download a copy of this white paper and explore the power of consumer-centric marketing. . Download a copy of this white paper and explore the power of consumer-centric marketing. Harness the power of “big tech” to build more targeted digital marketing content. Download Your Copy.

Marketing 52

Marketing Production 52